OBI Pharma, Inc. 4174.TWO Stock
OBI Pharma, Inc. Price Chart
OBI Pharma, Inc. 4174.TWO Financial and Trading Overview
| OBI Pharma, Inc. stock price | 61.5 TWD |
| Previous Close | 87.7 TWD |
| Open | 87.7 TWD |
| Bid | 88 TWD x 0 |
| Ask | 88.4 TWD x 0 |
| Day's Range | 87.7 - 87.9 TWD |
| 52 Week Range | 64.3 - 114 TWD |
| Volume | 304.96K TWD |
| Avg. Volume | 651.38K TWD |
| Market Cap | 20.23B TWD |
| Beta (5Y Monthly) | 1.209931 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.57 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4174.TWO Valuation Measures
| Enterprise Value | 17.63B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3863.8364 |
| Price/Book (mrq) | 4.571074 |
| Enterprise Value/Revenue | 3366.383 |
| Enterprise Value/EBITDA | -9.063 |
Trading Information
OBI Pharma, Inc. Stock Price History
| Beta (5Y Monthly) | 1.209931 |
| 52-Week Change | -21.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 114 TWD |
| 52 Week Low | 64.3 TWD |
| 50-Day Moving Average | 86.14 TWD |
| 200-Day Moving Average | 78.2 TWD |
4174.TWO Share Statistics
| Avg. Volume (3 month) | 651.38K TWD |
| Avg. Daily Volume (10-Days) | 525.5K TWD |
| Shares Outstanding | 228.86M |
| Float | 159.45M |
| Short Ratio | N/A |
| % Held by Insiders | 36.42% |
| % Held by Institutions | 5.01% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -41029.58% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.11% |
| Return on Equity (ttm) | -29.67% |
Income Statement
| Revenue (ttm) | 5.24M TWD |
| Revenue Per Share (ttm) | 0.02 TWD |
| Quarterly Revenue Growth (yoy) | 41.60% |
| Gross Profit (ttm) | -40144000 TWD |
| EBITDA | -1944819968 TWD |
| Net Income Avi to Common (ttm) | -1671609984 TWD |
| Diluted EPS (ttm) | -7.2 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.02B TWD |
| Total Cash Per Share (mrq) | 21.89 TWD |
| Total Debt (mrq) | 270.79M TWD |
| Total Debt/Equity (mrq) | 4.23 TWD |
| Current Ratio (mrq) | 36.826 |
| Book Value Per Share (mrq) | 19.339 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1636818048 TWD |
| Levered Free Cash Flow (ttm) | -1261967104 TWD |
Profile of OBI Pharma, Inc.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 3, Park Street |
| ZIP | 115 |
| Phone | 886 2 2655 8799 |
| Website | https://www.obipharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898 and OBI-998 drugs. The company was founded in 2002 and is headquartered in Taipei, Taiwan.
Q&A For OBI Pharma, Inc. Stock
What is a current 4174.TWO stock price?
OBI Pharma, Inc. 4174.TWO stock price today per share is 61.5 TWD.
How to purchase OBI Pharma, Inc. stock?
You can buy 4174.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for OBI Pharma, Inc.?
The stock symbol or ticker of OBI Pharma, Inc. is 4174.TWO.
Which industry does the OBI Pharma, Inc. company belong to?
The OBI Pharma, Inc. industry is Biotechnology.
How many shares does OBI Pharma, Inc. have in circulation?
The max supply of OBI Pharma, Inc. shares is 229.25M.
What is OBI Pharma, Inc. Price to Earnings Ratio (PE Ratio)?
OBI Pharma, Inc. PE Ratio is now.
What was OBI Pharma, Inc. earnings per share over the trailing 12 months (TTM)?
OBI Pharma, Inc. EPS is -4.57 TWD over the trailing 12 months.
Which sector does the OBI Pharma, Inc. company belong to?
The OBI Pharma, Inc. sector is Healthcare.